93315-84-5 Usage
Chemical structure
The compound consists of an indole ring structure with a benzyloxy substitution at the 5-position and a ketone functional group attached to the ethane side chain.
Indole moiety
Known for its biological activities such as anti-inflammatory, anticancer, and antimicrobial properties.
Benzyloxy group
Provides stability to the compound and can serve as a handle for further chemical modifications.
Ketone functional group
Reactive and can participate in various chemical reactions to form new compounds with different properties.
Versatility
The compound is versatile and can be used in organic synthesis and pharmaceutical research.
Therapeutic applications
Due to its potential therapeutic applications, it is commonly used in the field of medicinal chemistry and drug discovery.
Biological activity
The compound has potential therapeutic applications, which may include anti-inflammatory, anticancer, and antimicrobial properties.
Chemical modifications
The benzyloxy group allows for further chemical modifications, making the compound a useful starting point for the development of new drugs.
Organic synthesis
The compound is used in organic synthesis, which is the study of the formation and manipulation of carbon-containing compounds.
Pharmaceutical research
The compound is used in pharmaceutical research to develop new drugs and therapies for various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 93315-84-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,3,3,1 and 5 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 93315-84:
(7*9)+(6*3)+(5*3)+(4*1)+(3*5)+(2*8)+(1*4)=135
135 % 10 = 5
So 93315-84-5 is a valid CAS Registry Number.
InChI:InChI=1/C17H15NO2/c1-12(19)16-10-18-17-8-7-14(9-15(16)17)20-11-13-5-3-2-4-6-13/h2-10,18H,11H2,1H3
93315-84-5Relevant articles and documents
Weak Coordination-Guided Regioselective Direct Redox-Neutral C4 Allylation of Indoles with Morita-Baylis-Hillman Adducts
Pradhan, Sourav,De, Pinaki Bhusan,Punniyamurthy, Tharmalingam
supporting information, p. 9898 - 9903 (2019/12/24)
A weak carbonyl coordination-guided regioselective C4 allylation of indoles is demonstrated using the versatile Morita-Baylis-Hillman adduct in the presence of Rh catalysts in a redox-neutral fashion. The substrate scope, functional group diversity, oxidant free character, mechanistic aspects, and synthetic utilities are important practical features.
AMINO COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS
-
Paragraph 0514; 0515, (2017/03/14)
Compounds, methods of use, and processes for making inhibitors of complement Factor D comprising Formula I, or a pharmaceutically acceptable salt or composition thereof wherein R12 or R13 on the A group is an amino substituent (R32) are provided. The inhibitors of Factor D described herein reduce the excessive activation of complement.
ETHER COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS
-
Paragraph 0553, (2017/03/14)
Compounds, methods of use, and processes for making inhibitors of complement Factor D comprising Formula I, or a pharmaceutically acceptable salt or composition thereof wherein R12 or R13 on the A group is an ether substituent (R32) are provided. The inhibitors described herein target Factor D and inhibit or regulate the complement cascade. The inhibitors of Factor D described herein reduce the excessive activation of complement.
